EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients



Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients



Presse Medicale 21(6): 269-269




(PDF emailed within 1 workday: $29.90)

Accession: 041935556

Download citation: RISBibTeXText

PMID: 1372976



Related references

Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol. European Journal of Haematology 54(2): 73-77, 1995

Intensive treatment of AIDS-related non-Hodgkin's lymphomas with MACOP-B protocol. European Journal of Haematology 54(2): 73-77, 1995

Intensive treatment of AIDS-related non-Hodgkin lymphomas with the MACOP-B protocol Report on eight cases. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 427, 1993

Polychemotherapy of non-Hodgkin's centrofollicular malignant lymphomas. Review of 37 cases in advanced stage. Medicina Clinica 73(7): 267-273, 1979

Multicenter study of the treatment of highly malignant non-Hodgkin's lymphomas with polychemotherapy (CHOPV) and irradiation. Onkologie 10(1): 34-40, 1987

Nutritional support in non-Hodgkin's lymphoma treated with polychemotherapy MACOP-B cycle. Minerva Gastroenterologica E Dietologica 37(2): 117-121, 1991

Hodgkin lymphomas in HIV/AIDS patients when treated with combined antiretroviral therapy: further studies are needed for understanding the pathogenesis of developing Hodgkin lymphomas in HIV. Revista Da Sociedade Brasileira de Medicina Tropical 46(3): 385-386, 2014

Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathology and Applied Neurobiology 20(3): 243-252, 1994

AIDS-related B-cell non-Hodgkin's lymphomas in direct blood-stream HIV-infected patients: pathogenesis and differentiation features. International Journal of Cancer 45(5): 883-888, 1990

Opportunistic malignant lymphomas in SIV infected primates--a model for Epstein-Barr virus associated lymphomas in AIDS. Verhandlungen der Deutschen Gesellschaft für Pathologie 76: 189-193, 1992

The treatment of large-cell non-Hodgkin's lymphomas with the MACOP-B protocol. Medicina Clinica 97(14): 521-525, 1991

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas. Leukemia 5 Suppl 1: 74-78, 1991

MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas. Leukemia & Lymphoma 16(5-6): 457-463, 1995

MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. Annals of Oncology 2 Suppl 1: 17-23, 1991

Treatment of high-grade non-Hodgkin's lymphomas with short intensive chemotherapy (MACOP-B). Bulletin du Cancer (Paris) 80(9): 808-815, 1993